These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 12620407)

  • 1. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
    Freeman DJ; Li AG; Wei G; Li HH; Kertesz N; Lesche R; Whale AD; Martinez-Diaz H; Rozengurt N; Cardiff RD; Liu X; Wu H
    Cancer Cell; 2003 Feb; 3(2):117-30. PubMed ID: 12620407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
    Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
    J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of PTEN transcription by p53.
    Stambolic V; MacPherson D; Sas D; Lin Y; Snow B; Jang Y; Benchimol S; Mak TW
    Mol Cell; 2001 Aug; 8(2):317-25. PubMed ID: 11545734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
    Mayo LD; Donner DB
    Trends Biochem Sci; 2002 Sep; 27(9):462-7. PubMed ID: 12217521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
    Zhang C; Comai L; Johnson DL
    Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
    Chung TW; Lee YC; Ko JH; Kim CH
    Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN and p53: who will get the upper hand?
    Trotman LC; Pandolfi PP
    Cancer Cell; 2003 Feb; 3(2):97-9. PubMed ID: 12620402
    [No Abstract]   [Full Text] [Related]  

  • 13. PTEN regulates Mdm2 expression through the P1 promoter.
    Chang CJ; Freeman DJ; Wu H
    J Biol Chem; 2004 Jul; 279(28):29841-8. PubMed ID: 15090541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
    Weng LP; Brown JL; Eng C
    Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG
    Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
    Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
    J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
    Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
    Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
    Kulikov R; Boehme KA; Blattner C
    Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.